National
‘Unprecedented’: Vatican official apologizes to LGBTQ Catholics
Synod of Bishops deleted, reposted link to pro-LGBTQ video
In a development that Catholic Church observers consider to be unprecedented, a high-level Vatican official apologized last week to LGBTQ people and to the Mt. Rainier, Md., based LGBTQ Catholic group New Ways Ministry for removing from a Vatican open forum website a link to an LGBTQ supportive video on New Ways Ministry’s website.
The apology by Thierry Bonaventura, communication manager of the Vatican-based General Secretariat of the Synod of Bishops, came five days after New Ways Ministry released excerpts from two letters that Pope Francis sent to New Ways Ministry in May and June of 2021 praising the organization for its work in support of LGBTQ Catholics.
According to the National Catholic Reporter, conservative Catholic media outlets reported that Bonaventura removed the link to the New Ways Ministry video from the Synod’s website on Dec. 7 after he learned that the U.S. Conference of Catholic Bishops censured New Ways Ministry in 2010 because of its support for civil marriage for same-sex couples.
Supporters of New Ways Ministry believe Bonaventura may have issued his apology and subsequently reposted the video link to the Synod website after learning that the Pope himself had expressed a favorable opinion of New Ways Ministry in his recent letters to the LGBTQ ministry.
Francis DeBernardo, executive director of New Ways Ministry, said in a statement that the New Ways Ministry video, among other things, encourages LGBTQ people to participate in Synod consultations. The Synod provides advice to the Pope on a wide range of church-related matters.
DeBernardo said it was someone from the Vatican, not New Ways Ministry, who placed the link to the LGBTQ group’s video on the Synod’s website.
“In recent days, I have personally taken the initiative to de-publish a post promoted by the reality ‘New Ways Ministries’ for internal procedural reasons,” Bonaventura says in his apology, which he posted on Facebook. “This brought pain to the entire LGBTQ community who once again felt left out,” he said.
“I feel I must apologize to all LGBTQ people and to the members of New Ways Ministries for the pain caused,” Bonaventura said. He added that he reposted the link to the New Ways Ministry video on the Synod website. He also posted in his Facebook message a link to the Synod’s resources web page, suggesting that LGBTQ Catholics should submit messages on the site.
“Certainly, LGBTQ groups and those groups who feel they live on the ‘margins’ of the Church can direct their contributions, resources, or what they want to share with the whole people of God to [this website],” he wrote.
“New Ways Ministry warmly accepts the apology of Thierry Bonaventura,” DeBernardo said in a Dec. 13 statement. “Apologies are powerful in their ability to build bridges of reconciliation and justice,” DeBernardo said. “Mr. Bonaventura’s kind words and his reposting of the video will be effective in helping to repair the rift that exists between LGBTQ people and Catholic institutions,” he said.
“We appreciate that apologies are never easy to make,” DeBernardo continued. “New Ways Ministry had not requested one, making this gesture all the more authentic,” he said. “Vatican officials rarely apologize, and they almost certainly have never apologized to LGBTQ people or an LGBTQ Catholic Ministry,” said DeBernardo.
“This action signals that Vatican officials are becoming aware of how their decisions impact LGBTQ lives,” he said. “It also reveals a desire to repair damages they may have caused. In these respects, this is an historic moment.”
DeBernardo said Pope Francis’s two letters to New Ways Ministry came in response to messages that he sent to the Pope discussing problems LGBTQ people and New Ways Ministry have faced with Catholic Church officials, including the Vatican.
“We wrote to the Pope in April, introducing ourselves as an organization, providing him with a brief history, including two major censures by church officials,” DeBernardo told the Blade.
Among the issues he said his group raised with the Pope was a 1999 decision by the Vatican’s Congregation of the Doctrine for the Faith to prohibit the two co-founders of New Ways Ministry – Sister Jeannine Gramick and Father Robert Nugent – from engaging in pastoral work with gay people.
The National Catholic Reporter, which published a story about the Pope’s letters to New Ways Ministry, reports that the 1999 action against Gramick and Nugent was based on claims by Vatican officials that the two LGBTQ supporters promoted “ambiguities and errors” in their ministerial work.
The newspaper, which operates independently from the Catholic Church, points out in a Dec. 8 story that the notification sent to Gramick and Nugent prohibiting them from providing pastoral support for homosexuals was signed by then Cardinal Joseph Razinger, who later became Pope Benedict XVI.
DeBernardo told the Blade New Ways Ministry decided to release excerpts of the Pope’s two letters rather than the entire letters because some of the content “were pastoral and personal messages which it was not appropriate or relevant to release.” He said the decision to release the excepts was made after a National Catholic Reporter journalist contacted the group for comment after the newspaper learned that the link to the New Ways Ministry video had been removed from the Vatican based Synod’s website.
“We made the decision that we would let him know about the papal correspondence as a way to show that Pope Francis was indeed genuinely interested in LGBTQ people, as evidenced by the fact that he was in supportive correspondence with New Ways,” DeBernardo said.
“In two letters to New Ways Ministry this year, Pope Francis commended the organization for its outreach to the LGBTQ community and referred to one of its co-founders, Loretto Sister Jeannine Gramick, as ‘a valiant woman’ who suffered much from her ministry,” the newspaper reports.
“Written in Spanish on official Vatican stationary, Francis’ letters mention that the Pope is aware that New Ways Ministry’s ‘history has not been an easy one, but that loving one’s neighbor is still the second commandment, tied ‘necessarily’ to the first commandment to love God,” the National Catholic Reporter story continues.
“Thank you for your neighborly work,” the newspaper quoted Francis as telling DeBernardo in a June 17 letter. In that same letter, the Pope also expressed praise for Sister Gramick. “I know how much she has suffered. She is a valiant woman who makes her decisions in prayer,” the newspaper quoted the Pope as saying.
“It helped me a lot to know the full story you tell me about New Ways Ministry’s history,” the newspaper further quoted the Pope as saying in a May 3 letter. “Sometimes we receive partial information about people and organizations, and this doesn’t help. Your letter, as it narrates with objectivity its history, gives me light to better understand certain situations,” National Catholic Reporter quoted the Pope as saying to DeBernardo in the May 3 letter.
“In ongoing communications with us and with others, it is clear that Pope Francis wants LGBTQ ministry to thrive,” DeBernardo said in a Dec. 13 statement. “He has publicly emphasized that he wants all people to participate in synod discussions, especially those who have been marginalized or alienated from the church,” he said.
“This unprecedented apology from a Vatican office corrects the earlier mistake and amplifies, even louder, the welcome that Pope Francis has extended to LGBTQ people,” said DeBernardo.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
